By Lucky Uwakina (AGENDAWATCHDOG) – U.S. officials have officially said vaccinations with Johnson & Johnson’s one-dose shot can resume, the Centers for Disease Control and Prevention (CDC) and Food and Drug Administration (FDA) said in a joint statement issued Friday night.
Centers for Disease Control and Prevention (CDC) director Dr Rochelle Walensky said that vaccinations with the J&J shot can resume ‘immediately’ during a Friday press conference.
Vaccinations could resume as early as tomorrow, said Dr Peter Marks, director of the FDA’s Center for Biologics Evaluation and Research. Shots can resume once updated materials about the risks of blood clots go out to vaccination clinics and health care providers.
Dr Walensky confirmed that there is ‘likely’ an association between the vaccine and the combination of blood clots and low platelet counts seen in 15 women during the rollout of the shot.
However, the rates were so low that officials believe that the risks do not outweigh the considerable benefits experts predict the shot will have.
An expert panel recommended earlier on Friday that the pause on Johnson & Johnson vaccinations be lifted without any added restrictions or warnings.